Literature DB >> 25395460

The brain microenvironment: friend or foe for metastatic tumor cells?

Frank Winkler1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25395460      PMCID： PMC4232092          DOI： 10.1093/neuonc/nou308

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  15 in total

1.  Gap junctions propagate opposite effects in normal and tumor testicular cells in response to cisplatin.

Authors:  Xiaoting Hong; Qin Wang; Yan Yang; Suping Zheng; Xuhui Tong; Suzhi Zhang; Liang Tao; Andrew L Harris
Journal:  Cancer Lett       Date:  2011-11-22       Impact factor: 8.679

2.  Real-time imaging reveals the single steps of brain metastasis formation.

Authors:  Yvonne Kienast; Louisa von Baumgarten; Martin Fuhrmann; Wolfgang E F Klinkert; Roland Goldbrunner; Jochen Herms; Frank Winkler
Journal:  Nat Med       Date:  2009-12-20       Impact factor: 53.440

Review 3.  Tissue concentration of systemically administered antineoplastic agents in human brain tumors.

Authors:  Marshall W Pitz; Arati Desai; Stuart A Grossman; Jaishri O Blakeley
Journal:  J Neurooncol       Date:  2011-03-12       Impact factor: 4.130

4.  Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a multicenter phase II trial (GFPC 07-01).

Authors:  F Barlesi; R Gervais; H Lena; J Hureaux; H Berard; D Paillotin; S Bota; I Monnet; A Chajara; G Robinet
Journal:  Ann Oncol       Date:  2011-02-14       Impact factor: 32.976

5.  Reactive astrocytes protect melanoma cells from chemotherapy by sequestering intracellular calcium through gap junction communication channels.

Authors:  Qingtang Lin; Krishnakumar Balasubramanian; Dominic Fan; Sun-Jin Kim; Lixia Guo; Hua Wang; Menashe Bar-Eli; Kenneth D Aldape; Isaiah J Fidler
Journal:  Neoplasia       Date:  2010-09       Impact factor: 5.715

6.  Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer.

Authors:  Paul R Lockman; Rajendar K Mittapalli; Kunal S Taskar; Vinay Rudraraju; Brunilde Gril; Kaci A Bohn; Chris E Adkins; Amanda Roberts; Helen R Thorsheim; Julie A Gaasch; Suyun Huang; Diane Palmieri; Patricia S Steeg; Quentin R Smith
Journal:  Clin Cancer Res       Date:  2010-09-09       Impact factor: 12.531

Review 7.  Brain metastases as preventive and therapeutic targets.

Authors:  Patricia S Steeg; Kevin A Camphausen; Quentin R Smith
Journal:  Nat Rev Cancer       Date:  2011-04-07       Impact factor: 60.716

8.  Astrocytes upregulate survival genes in tumor cells and induce protection from chemotherapy.

Authors:  Sun-Jin Kim; Jang-Seong Kim; Eun Sung Park; Ju-Seog Lee; Qingtang Lin; Robert R Langley; Marva Maya; Junqin He; Seung-Wook Kim; Zhang Weihua; Krishnakumar Balasubramanian; Dominic Fan; Gordon B Mills; Mien-Chie Hung; Isaiah J Fidler
Journal:  Neoplasia       Date:  2011-03       Impact factor: 5.715

Review 9.  The perivascular niche microenvironment in brain tumor progression.

Authors:  Nikki Charles; Eric C Holland
Journal:  Cell Cycle       Date:  2010-08-01       Impact factor: 4.534

10.  The vascular basement membrane as "soil" in brain metastasis.

Authors:  W Shawn Carbonell; Olaf Ansorge; Nicola Sibson; Ruth Muschel
Journal:  PLoS One       Date:  2009-06-10       Impact factor: 3.240
View more
  2 in total

Review 1.  Cancer and the metastatic substrate.

Authors:  Francisco Arvelo; Felipe Sojo; Carlos Cotte
Journal:  Ecancermedicalscience       Date:  2016-12-08

Review 2.  [Tumor Cells and Micro-environment in Brain Metastases].

Authors:  Wen Zhong; Chengping Hu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-09-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.